Aptose Biosciences, Inc. (APTO): Price and Financial Metrics


Aptose Biosciences, Inc. (APTO): $0.75

0.01 (+1.23%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add APTO to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

APTO Stock Price Chart Interactive Chart >

Price chart for APTO

APTO Price/Volume Stats

Current price $0.75 52-week high $1.55
Prev. close $0.74 52-week low $0.43
Day low $0.74 Volume 368,729
Day high $0.76 Avg. volume 272,980
50-day MA $0.64 Dividend yield N/A
200-day MA $0.77 Market Cap 69.22M

Aptose Biosciences, Inc. (APTO) Company Bio


Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. The company was founded in 1986 and is based in Mississauga, Canada.


APTO Latest News Stream


Event/Time News Detail
Loading, please wait...

APTO Latest Social Stream


Loading social stream, please wait...

View Full APTO Social Stream

Latest APTO News From Around the Web

Below are the latest news stories about APTOSE BIOSCIENCES INC that investors may wish to consider to help them evaluate APTO as an investment opportunity.

Aptose Biosciences Inc. (NASDAQ: APTO): Can A Stock That’s Down -57.04% YTD Still Be Considered In Loss Territory?

During the last session, Aptose Biosciences Inc. (NASDAQ:APTO)’s traded shares were 0.38 million, with the beta value of the company hitting 1.54. At the end of the trading day, the stock’s price was $0.58, reflecting an intraday gain of 7.61% or $0.04. The 52-week high for the APTO share is $1.55, that puts it down … Aptose Biosciences Inc. (NASDAQ: APTO): Can A Stock That’s Down -57.04% YTD Still Be Considered In Loss Territory? Read More »

Marketing Sentinel | December 31, 2022

We Think Aptose Biosciences (TSE:APS) Needs To Drive Business Growth Carefully

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Yahoo | December 30, 2022

Aptose Biosciences to Present at Biotech Showcase 2023 Conference

SAN DIEGO and TORONTO, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, will participate at the upcoming Biotech Showcase 2023 Conference

Wallstreet:Online | December 28, 2022

Aptose Biosciences to Present at Biotech Showcase™ 2023 Conference

SAN DIEGO and TORONTO, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, will participate at the upcoming Biotech Showcase™ 2023 Conference on Tuesday, January 10th, 2023, at 10:00 a.m. PST in San Francisco, CA. Conference Presentation D

Yahoo | December 28, 2022

How did Aptose Biosciences Inc. (APTO) fare last session?

A share of Aptose Biosciences Inc. (NASDAQ:APTO) closed at $0.65 per share on Tuesday, down from $0.71 day before. While Aptose Biosciences Inc. has underperformed by -8.45%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, APTO fell by -66.67%, with highs and lows ranging from $2.00 […]

US Post News | December 14, 2022

Read More 'APTO' Stories Here

APTO Price Returns

1-mo 29.31%
3-mo 36.36%
6-mo -9.63%
1-year -42.31%
3-year -89.07%
5-year -74.40%
YTD 29.31%
2022 -57.04%
2021 -69.18%
2020 -22.75%
2019 196.86%
2018 -14.73%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.602 seconds.